Nkarta Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:NKTX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Jan 24SellUS$84,752Paul HastingsIndividual9,697US$8.74
16 Jan 24SellUS$39,802Alicia HagerIndividual4,554US$8.74
16 Jan 24SellUS$21,955Ralph BrandenbergerIndividual2,512US$8.74
16 Jan 24SellUS$39,854James TragerIndividual4,560US$8.74
16 Jan 24SellUS$31,044David ShookIndividual3,552US$8.74
21 Aug 23SellUS$2,436David ShookIndividual1,331US$1.83
20 Jun 23SellUS$8,264Paul HastingsIndividual1,704US$4.85
20 Jun 23SellUS$2,551Nadir MahmoodIndividual526US$4.85
20 Jun 23SellUS$2,129David ShookIndividual439US$4.85
20 Jun 23SellUS$3,400Alicia HagerIndividual701US$4.85
20 Jun 23SellUS$1,072Ralph BrandenbergerIndividual221US$4.85
20 Jun 23SellUS$2,129James TragerIndividual439US$4.85

Insider Trading Volume

Insider Buying: NKTX insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of NKTX?
Owner TypeNumber of SharesOwnership Percentage
Private Companies89,5400.181%
Individual Insiders191,0120.387%
General Public1,750,4653.54%
Hedge Funds9,580,00019.4%
Institutions16,319,33533%
VC/PE Firms21,485,83443.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 43.9%.


Top Shareholders

Top 25 shareholders own 89.37% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.8%
RA Capital Management, L.P.
7,805,129US$116.7m0%0.92%
8.92%
Tavistock Life Sciences
4,407,350US$65.9m206%2.15%
7.22%
New Enterprise Associates, Inc.
3,568,781US$53.4m0%1.51%
6.98%
Adage Capital Management, L.P.
3,450,000US$51.6m2,380%0.06%
6.88%
Deerfield Management Company, L.P. Series C
3,400,000US$50.8m0%0.57%
5.8%
Samsara BioCapital LLC
2,868,035US$42.9m0%4.26%
5.74%
EQT Life Sciences
2,836,539US$42.4m30.7%11.91%
5.52%
Commodore Capital LP
2,730,000US$40.8m0%1.64%
5.26%
BlackRock, Inc.
2,599,201US$38.9m-10.1%no data
4.25%
Wasatch Advisors LP
2,099,699US$31.4m13.6%0.07%
3.16%
The Vanguard Group, Inc.
1,560,518US$23.3m4.12%no data
2.7%
SR One Capital Management, LP
1,333,333US$19.9m0%2.62%
1.33%
Renaissance Technologies LLC
657,772US$9.8m28.3%0.01%
1.32%
Geode Capital Management, LLC
653,740US$9.8m3.32%no data
1.24%
State Street Global Advisors, Inc.
611,849US$9.1m0.75%no data
1.11%
Tang Capital Management, LLC
550,000US$8.2m-50.2%0.5%
0.94%
T. Rowe Price Group, Inc.
462,838US$6.9m-89.7%no data
0.91%
Alyeska Investment Group, L.P.
450,731US$6.7m-54.9%0.03%
0.77%
Bridgeway Capital Management, LLC
379,467US$5.7m-37.3%0.06%
0.7%
Superstring Capital Management LP
347,381US$5.2m0%2.52%
0.68%
JP Morgan Asset Management
337,607US$5.0m-5.49%no data
0.65%
Northern Trust Global Investments
320,749US$4.8m-0.58%no data
0.51%
Marshall Wace LLP
250,667US$3.7m0%no data
0.51%
Jefferies Financial Group Inc.,Asset Management Arm
250,000US$3.7m0%0.04%
0.47%
Medical Strategy GmbH, Asset Management Arm
230,782US$3.5m0%0.11%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.